These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25014290)

  • 41. [Facilitating factors and difficulties in the the implementation of sanitary surveillance of drugstores in Salvador, state of Bahia, Brazil].
    Bastos AA; Costa EA; de Castro LL
    Cien Saude Colet; 2011 Sep; 16(9):3863-72. PubMed ID: 21987329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal].
    Portela MC; Sinogas C; Almeida FA; Baptista-Leite R; Castro-Caldas A
    Acta Med Port; 2017 Mar; 30(3):205-212. PubMed ID: 28550830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application.
    Nuruzzaman M; Rahman MM; Liu Y; Naidu R
    J Agric Food Chem; 2016 Feb; 64(7):1447-83. PubMed ID: 26730488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Update of the Brazilian Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products.
    Soares KC; Santos GM; Gelfuso GM; Gratieri T
    AAPS J; 2015 Nov; 17(6):1517-8. PubMed ID: 26122498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanotechnological medical devices and nanopharmaceuticals: the European regulatory framework and research needs.
    Rickerby DG
    J Nanosci Nanotechnol; 2007 Dec; 7(12):4618-25. PubMed ID: 18283854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
    Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
    Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of work scenarios in the sanitary enforcement of medicines from the federal regulatory agency.
    Martins MAF; Scherer MDDA
    Cien Saude Colet; 2023 Oct; 28(10):2891-2902. PubMed ID: 37878932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Profile of mortality by intoxication with medication in Brazil, 1996-2005: portrait of a decade].
    Mota DM; Melo JR; de Freitas DR; Machado M
    Cien Saude Colet; 2012 Jan; 17(1):61-70. PubMed ID: 22218540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacovigilance implementation and operational conditions in the pharmaceutical industry in São Paulo State, Brazil].
    Freitas MS; Romano-Lieber NS
    Cad Saude Publica; 2007 Jan; 23(1):167-75. PubMed ID: 17187115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.
    Smith MY; Benattia I
    Drug Saf; 2016 Sep; 39(9):779-85. PubMed ID: 27098248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Self-medication: Is regulation needed...from whom?].
    Caulin C; Cranz H
    Therapie; 2000; 55(4):547-53. PubMed ID: 11098734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Historical evolution of package inserts in Brazil].
    Caldeira TR; Neves ER; Perini E
    Cad Saude Publica; 2008 Apr; 24(4):737-43. PubMed ID: 18392350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products.
    Rodríguez-Gómez FD; Monferrer D; Penon O; Rivera-Gil P
    Front Med (Lausanne); 2023; 10():1308047. PubMed ID: 38298514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Advanced therapy: from European regulatory framework to national regulatory framework].
    Lucas-Samuel S
    Transfus Clin Biol; 2013 May; 20(2):221-4. PubMed ID: 23517820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Work in health: sanitary surveillance of drugstores in Salvador (state of Bahia, Brazil)].
    Bastos AA; Costa EA; de Castro LL
    Cien Saude Colet; 2011 May; 16(5):2391-400. PubMed ID: 21655712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Work-related Mental Health Surveillance in Brazil: characteristics, difficulties, and challenges.
    de Araújo TM; Araújo TM; Palma TF; Araújo NDC
    Cien Saude Colet; 2017 Oct; 22(10):3235-3246. PubMed ID: 29069180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges for the formulation, implantation and implementation of a National Health Surveillance Policy in Brazil.
    Guimarães RM; Meira KC; Paz EPA; Dutra VGP; Campos CEA
    Cien Saude Colet; 2017 May; 22(5):1407-1416. PubMed ID: 28538913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bioequivalence of dermatological topical medicines:the Brazilian scenario and the challenges for health surveillance].
    Soares KC; Moraes MV; Gelfuso GM; Gratieri T
    Cien Saude Colet; 2015 Nov; 20(11):3599-608. PubMed ID: 26602737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication errors through a national pharmacovigilance database approach: a study for Malta.
    Tanti A; Camilleri M; Bonanno PV; Borg JJ
    Int J Risk Saf Med; 2013 Jan; 25(1):17-27. PubMed ID: 23442294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Conclusions. The precautionary principle: its advantages and risks].
    Tubiana M
    Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.